Publications by authors named "Aniko Barta"

Claim this Profile
D
Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning.
Attila Tordai, Andras Bors, Katalin Piroska Kiss, Katalin Balassa, Hajnalka Andrikovics, Aniko Barta

PLoS One· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation "MSC-FFM"-Outcome Report of 92 Patients.
Halvard Bonig, Zyrafete Kuçi, Selim Kuçi, Shahrzad Bakhtiar, Oliver Basu, Aniko Barta

Cells· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM).
Peter Bader, Zyrafete Kuçi, Shahrzad Bakhtiar, Oliver Basu, Gesine Bug, Aniko Barta

Bone Marrow Transplant· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-specific survival difference in association with HLA-DRB1∗04 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies.
Katalin Balassa, Hajnalka Andrikovics, Peter Remenyi, Arpad Batai, Aniko Szilvasi, Aniko Barta

Hum Immunol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recipient and donor JAK2 46/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Katalin Balassa, Tunde Krahling, Peter Remenyi, Arpad Batai, Andras Bors, Aniko Barta

Leuk Lymphoma· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Allogeneic hematopoietic stem cell transplantation in Hungary].
Árpád Bátai, Péter Reményi, Marienn Réti, Anikó Barta, László Gopcsa

Orv Hetil· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood stem cell mobilization and engraftment after autologous stem cell transplantation with biosimilar rhG-CSF.
Péter Reményi, László Gopcsa, Imelda Marton, Marienn Réti, Gábor Mikala, Anikó Barta

Adv Ther· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia patients.
Nóra Meggyesi, András Kozma, Gabriella Halm, Sarolta Nahajevszky, Arpád Bátai, Anikó Barta

Acta Haematol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR-ABL transcripts.
Hajnalka Andrikovics, Sarolta Nahajevszky, Anikó Szilvási, András Bors, Emma Adám, Anikó Barta

Hematol Oncol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring the level of complement components during autologous blood stem cell transplantation in patients with malignant lymphomas.
Aniko Banyai, Lilian Varga, Aniko Barta, Laszlo Gopcsa, Katalin Paloczi

Cancer Immunol Immunother· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage chemotherapy with donor lymphocyte infusion and STI 571 in a patient relapsing with B-lymphoblastic phase chronic myeloid leukemia after allogeneic bone marrow transplantation.
László Gopcsa, Anikó Barta, Anikó Bányai, János Dolgos, Gabriella Halm

Pathol Oncol Res· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homogeneous immunoglobulins following allogeneic bone marrow transplantation.
Melinda Hajdu, Eva Puskás, Andrea Sipos, Anikó Barta, Katalin Pálóczi

Acta Haematol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis